Bioinformatic Analysis of Next Generation Sequencing Data from Cancer Cells

癌细胞下一代测序数据的生物信息学分析

• 批准号: 9762065
• 负责人: Elizabeth Thomas Bartom
• 金额: $ 17.4万
• 依托单位: NORTHWESTERN UNIVERSITY AT CHICAGO
• 依托单位国家: 美国
• 财政年份: 2017
• 资助国家: 美国
• 起止时间: 2017-09-19 至 2022-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9762065
• 关键词: Base Sequence; Big Data; Biochemistry; Bioinformatics; Biological; Biological Assay; Biology; Cancer Research Project; Cell Death; Cell physiology; Childhood Malignant Brain Tumor; Collaborations; Computational Biology; Computer Analysis; Data; Data Set; Development; Disease; Funding; Genetic Transcription; Goals; Histone H3; Histones; Lead; Malignant Childhood Neoplasm; Malignant Neoplasms; Methionine; Molecular; Molecular Genetics; Mutation; Proteins; Reproducibility; Research Personnel; Role; Transcriptional Elongation Factors; Universities; cancer cell; cancer type; chromatin protein; high standard; insight; leukemia; mutant; next generation sequencing; targeted cancer therapy; tumor progression

Project Summary This proposal supports the bioinformatics needs of two NCI funded Outstanding Investigators at the Northwestern University Department of Biochemistry and Molecular Genetics. One project, with Dr. Ali Shilatifard, examines the role of mutations in histone modifiers such as MLL in the progression of cancer. A recent discovery on the stabilization of mutant proteins relative to wildtype gives insight into one cause of disease and a new target for cancer therapy. Another project examines the role of transcription elongation factors in cancer development. These proteins are often fused to MLL in leukemia, but it is not clear why general transcriptional regulators lead to specific types of cancer. A third project examines another chromatin protein, histone H3, and how mutation of H3K27 to methionine can lead to specific types of pediatric brain cancer. Here too, new understanding of the molecular mechanism of the disease has led to a new line of therapy for this currently incurable and devastating childhood cancer. A fourth project, in collaboration with Dr. Marcus Peter, examines another fundamental cellular process, DISE, and how it might be exploited to trigger cell death specifically in cancer cells. The common thread in all of these projects is the need for careful, biologically motivated computational analysis to make sense of next generation sequencing data that is essential in examining the function of cancer cells, both before and after perturbation. Dr. Bartom will provide this analysis, and her expertise in both biology and computation will allow cancer biologists to extract more insight from their data, and to maintain a high standard of scientific rigor and reproducibility.

项目摘要 该建议支持两名NCI资助的杰出调查员的生物信息学需求 西北大学生物化学和分子遗传学系。一个项目，与阿里博士 Shilatifard检查了突变在组蛋白修饰剂中（例如MLL）在癌症进展中的作用。一个 关于突变蛋白相对于野生型稳定的最新发现，可以洞悉 疾病和癌症治疗的新靶标。另一个项目检查了转录伸长的作用 癌症发展的因素。这些蛋白质通常融合在白血病中，但尚不清楚为什么 一般的转录调节剂会导致特定类型的癌症。第三个项目检查了另一种染色质 蛋白质，组蛋白H3以及H3K27对甲硫氨酸的突变如何导致特定类型的小儿大脑 癌症。在这里，对疾病分子机制的新理解已导致了一条新线 目前无法治愈且破坏性的儿童癌症的治疗。与博士合作的第四个项目 马库斯·彼得（Marcus Peter）检查了另一个基本的细胞过程，疾病以及如何利用它以触发 细胞死亡专门在癌细胞中。所有这些项目中的共同点是需要小心， 具有生物动机的计算分析以理解下一代测序数据 在扰动前后，检查癌细胞功能至关重要。 Bartom博士将提供 这种分析以及她在生物学和计算方面的专业知识将使癌症生物学家提取更多 从他们的数据中洞悉，并保持高标准的科学严谨性和可重复性。